HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moez Dungarwalla Selected Research

Methylprednisolone

3/2008High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moez Dungarwalla Research Topics

Disease

1MINOCA
07/2021
1Myocardial Infarction
07/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2008

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
07/2021
1fludarabineIBA
03/2008
1Rituximab (Mabthera)FDA Link
03/2008
1MethylprednisoloneFDA LinkGeneric
03/2008

Therapy/Procedure

1Therapeutics
03/2008